During the past decade, MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie" are "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "Stage IV Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie" in a lesser frequency.

Most popular intervention types in "MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "eHealth system support for symptom management via CANKADO" (1 trials). Other intervention names were less common.

The vast majority of trials in "MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ II der Niels Stensen Kliniken, Onkologie u. Hämatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".